Featuring Spatial Thermal Imaging©

Non-Invasive, High-Resolution Visualization of Internal Anatomical Features

Spatial Thermal Imaging (STI), developed by ThermEval, is a groundbreaking technology that transforms standard thermal images into highly detailed visualizations of internal anatomical features. With spatial resolution comparable to MRI, STI processes each image pixel to deliver detailed visualizations of blood vessels, cysts, other benign conditions, and malignant tumors. STI's greatest power is its ability to identify and process the subtle thermal signatures associated with the earliest metabolic changes in breast tissue, enabling visualization of malignant growths years before they are detectable through traditional methods.

STI embodies a deeper comprehension and knowledge. It's not only about seeing more; it's about knowing more and being empowered with the ability to make informed decisions and tailor treatment strategies effectively.

The efficacy of STI is strikingly illustrated in the following images showcasing a cluster of three malignant tumors, indicated by a yellow arrow. Notably, the smallest tumor in the cluster (upper-right), spans approximately 2mm!


STI, Breast Thermography and Early Breast Cancer Detection

Non-contact, non-invasive, infrared-based breast thermography is highly effective in identifying high-risk cases of breast cancer, as abnormal images are excellent prognosticators. However, it is unreliable in predicting low-risk outcomes, as some signs are imperceptible, and the limited signs identified in borderline and equivocal images can indicate various benign conditions. This uncertainty in interpreting results can lead to false reassurance for patients classified as low-risk. Statistics reveal between ten to twenty-five percent of patients classified as low-risk have a malignant tumor.

STI was developed to address the previous uncertainty and investigate the causes of cancer in cases categorized as low-risk. STI surpassed all expectations by demonstrating exceptional thermal sensitivity and spatial resolution; it was able to detect nascent tumors as small as approximately 2mm!

To assess its efficacy, an STI screening was conducted on 1,675 patients. The results revealed that between 10% and 25% of the low-risk outcomes were actually cancerous. This remarkable finding emphasizes STI's ability to identify nascent malignant tumors, achieving a Positive Predictive Value of 95%.

Breast cancer survival rates have seen significant improvements over time, yet the mortality rate and instances of metastatic breast cancer have largely remained constant. This stagnation is partly due to the limitations of current diagnostic methods to detect tumors at their early stages. In this context, STI represents a pivotal advancement as it can identify breast tumors at their nascent stages, substantially earlier than what is possible with existing screening techniques.

Awards and Recognition

ThermEval is proud of its accolade from Healthcare Business Review as Top Radiology Solutions Provider. This recognition is a testament to our innovative approach in the imaging field, particularly our contribution of Spatial Thermal Imaging to medical imaging. We are also delighted to celebrate the achievement of our affiliate, Thermogram Assessment Services (TAS) which by employing STI, has been honored as Best International Breast Thermal Image Interpretation Clinic - USA by Global Health & Pharma Magazine.

In summary, Spatial Thermal Imaging (STI) is an award-winning and groundbreaking development in the detection of breast cancer. This technology uses readily available and cost-effective equipment that is already being used in thousands of medical practices. The safety, affordability, and precision in identifying early-stage malignancies demonstrate that STI is a significant leap forward in breast cancer screening and detection, and it presents a promising avenue for primary screening, with the potential to reduce breast cancer mortality and the spread of the disease.